What is the Fiscal Year for Nurix Therapeutics?
Date: November 13, 2026
Nurix Therapeutics's current fiscal year starts on December 1, 2025, and ends on November 30, 2026. Their current quarter is Q4, which ends on November 30, 2026.
Current Fiscal Year Overview
Fiscal Year Start
December 1, 2025
Fiscal Year End
November 30, 2026
Current Quarter
Q4
Current Quarter End
November 30, 2026
Quarterly Breakdown
Q1
Dec 1, 2025 – Feb 28, 2026
Q2
Mar 1, 2026 – May 31, 2026
Q3
Jun 1, 2026 – Aug 31, 2026
Q4
Sep 1, 2026 – Nov 30, 2026
Company Information
Headquarters
Brisbane, California
Industry
Biotechnology
Stock Symbol
NRIX
Website
https://nurixtx.comDescription
Important Notice to Candidates: Nurix representatives with never conduct interviews by text and will never request personal financial information or ask candidates to purchase equipment. At Nurix Therapeutics, we aim to fundamentally change the way disease is treated using degrader-based medicines. Our journey began with a vision to harness the power of the cell’s natural protein degradation machinery, the ubiquitin-proteasome system, to create a new class of therapeutics that can overcome the limitations of current treatments.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Nurix Therapeutics and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.